Albania, Australia, Belgium, Canada, Denmark, France, Germany, Iceland, Ireland, Italy, Japan, Lithuania, Poland, Republic of Korea, Spain, Turkey, United Kingdom of Great Britain and Northern Ireland, United States of America.
麻醉药品委员会第四十八届会议的报告所载建议